☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
KSQ Therapeutics
KSQ Therapeutics Entered into a Worldwide License Agreement with Roche to Develop and Commercialize KSQ-4279 for Cancer
July 13, 2023
PharmaShots Weekly Snapshot (October 14-18, 2019)
October 21, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
